Get startedLog in
    Picture of POINT Biopharma Global logo

    PNT — POINT Biopharma Global News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Eli Lilly to buy Point Biopharma for $1.4 billion

    Picture of POINT Biopharma Global logoPOINT Biopharma Global
    03/10/2023 11:51
    Oct 3 (Reuters) - Eli Lilly and Co  LLY.N  has agreed to
acquire Point Biopharma Global  PNT.O  in an all-cash deal
valued at $1.4 billion, the two companies said on Tuesday.

 (Reporting by Leroy Leo in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))

    Recent news on POINT Biopharma Global

    See all news